Isoflavones impair anti-PD1 efficacy in breast cancer, regardless of dietary fiber or fecal short-chain fatty acid levels - Top-Institutions - MDSpire

Isoflavones impair anti-PD1 efficacy in breast cancer, regardless of dietary fiber or fecal short-chain fatty acid levels

  • By

  • Fabia de Oliveira Andrade

  • Kerrie B. Bouker

  • Melike Ozgul-Onal

  • Lu Jin

  • Idalia Cruz

  • William Helferich

  • Audrey Gao

  • Karla Andrade de Oliveira

  • Vivek Verma

  • Christopher Staley

  • Patricia L. Foley

  • Leena Hilakivi-Clarke

  • July 6, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    University of Minnesota Genomics Center (UMGC)
    University of Minnesota Genomics Center (UMGC)

    Minneapolis, MN

    Key Differentiators

    • Oncology

  • #2

    Georgetown University
    Georgetown University

    Washington, DC

    Key Differentiators

    • Oncology

  • #3

    Hormel Institute-UMN
    Hormel Institute-UMN

    Austin, MN

    Key Differentiators

    • Oncology

  • #4

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Oncology

  • #5

    Boston University Chobanian & Avedisian School of Medicine
    Boston University Chobanian & Avedisian School of Medicine

    Boston, MA

    Key Differentiators

    • Oncology

Original Source(s)

Isoflavones impair anti-PD1 efficacy in breast cancer, regardless of dietary fiber or fecal short-chain fatty acid levels

  • by Fabia de Oliveira Andrade, Kerrie B. Bouker, Melike Ozgul-Onal, Lu Jin, Idalia Cruz, William Helferich, Audrey Gao, Karla Andrade de Oliveira, Vivek Verma, Christopher Staley, Patricia L. Foley, Leena Hilakivi-Clarke

  • July 6, 2026

Related Content

A study on the prognostic assessment of triple-negative breast cancer using habitat analysis of preoperative DCE-MRI subtraction maps

A multiscale model reveals how ERK/p38-regulated dormancy shapes tumor-immune dynamics and immunoediting outcomes

A super-elderly patient with distal biliary tract cancer and tumor-associated granuloma: a case report